购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

TR-14035

Rating icon 很棒
产品编号 T5310Cas号 232271-19-1
别名 MDK-1191

TR-14035 (MDK-1191) 是一种具有口服活性的 α4β7/α4β1整合素双重抑制剂,对 α4β7和 α4β1作用的 IC50值分别为 7 和 87 nM,可用于炎症和自体免疫疾病的研究。

TR-14035
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

TR-14035

Rating icon 很棒
纯度: 99.81%
产品编号 T5310 别名 MDK-1191Cas号 232271-19-1

TR-14035 (MDK-1191) 是一种具有口服活性的 α4β7/α4β1整合素双重抑制剂,对 α4β7和 α4β1作用的 IC50值分别为 7 和 87 nM,可用于炎症和自体免疫疾病的研究。

规格价格库存数量
1 mg¥ 407现货
5 mg¥ 942现货
10 mg¥ 1,430现货
25 mg¥ 2,380现货
50 mg¥ 3,400现货
100 mg¥ 4,750现货
200 mg¥ 6,390现货
1 mL x 10 mM (in DMSO)¥ 978现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"TR-14035"的相关化合物库

选择批次:
纯度:99.81%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
TR-14035 (MDK-1191) is a dual antagonist of α4β7/α4β1 integrins (IC50s: 7/87nM).
靶点活性
α4β7 integrin:7 nM, α4β1 integrin:87 nM
体外活性
TR-14035(IC50:alpha(4)beta(7)/alpha(4)beta(1)=7/87 nM)已完成欧洲的第一阶段研究[1]。在大鼠和人类肝细胞中,TR-14035的摄取是通过一个明显的单一饱和机制进行的,其K(m)分别为6.7和2.1 microM,而牛磺胆酸和地高辛可以减少这种摄取。在卵母细胞中表达的OATP1B1/OATP-C 和 OATP1B3/OATP8介导了TR-14035的摄取,其K(m)分别为7.5和5.3 microM[2]。TR14035阻断了人类alpha(4)beta(7)与(125)I-MAdCAM-Ig融合蛋白的结合,IC(50)值为0.75 nM。在体外剪切流条件下,TR14035阻断了表达人类alpha(4)beta(7)的RPMI-8866细胞或小鼠肠系膜淋巴结淋巴细胞与MAdCAM-Ig的结合,IC(50)值为0.1 microM[3]。
体内活性
在EHBRs中,未变化的TR-14035的胆汁排泄和全身清除率显著低于正常大鼠,而在野生型与mdr1a/b-或Bcrp基因敲除小鼠之间,清除率无显著差异[2]。TR14035阻断了对HEVs的粘附(ED50:0.01-0.1 mpk i.v.)[3]。
细胞实验
RPMI8866 cell line and Jurkat T lymphoblastoid cell line were grown as a suspension culture in RPMI 1640 media, 10% FCS, 2 mM glutamine, 100 units/mL penicillin G, 100 mg/mL streptomycin sulfate at 37 °C and 5% CO2. Adhesion assays have been detailed elsewhere. Microtiter plates were coated with 20 mg/mL HSA for 2 h at room temperature, washed once with PBS and derivatized with 10 mg/mL SPDP for 1 h. After washing, CS-1 (or sCS-1) derived peptide solution (100 mL at 100 μg/mL) was added to the wells and allowed to crosslink to the plates overnight at 4 °C. Non-reacted sites were blocked with 100 mL of 1% OV in PBS for 1 h at 37 °C. RPMI8866 cells were suspended in Dulbecco's modified Eagle's medium with 0.25% OV at a density of 2.5 ×106/mL and incubated for ~1 h at 37 °C with varying concentrations of antagonists on peptide-coated plates. Following washing (EL404 plate washer), bound cells were quantified by measuring endogenous N-acetyl-hexosaminidase activity by reading the optical density at 405 nm using the enzyme substrate p-nitrophenol-N-acetyl-b-d-glucoseaminide. IC50 values were generated by nonlinear regression from titration curves of antagonists from seven doses and reported as the average of a minimum of two experiments. Since experimental variability was noted with respect to the IC50 of the internal standard [(1S - cis) - N - [(3 - carboxy - 2,2,3 - trimethylcyclopentyl)- carbonyl]-O-[(2,6-dichlorophenyl)methyl]-l-tyrosine] a normalization procedure was done using the global mean value [IC50=0.224±0.17 μM (N=19)] of the internal standard. For the Jurkat cell adhesion assay, OV was replaced with 0.25% HSA for both blocking and adhesion buffers. Standard error of the mean for the Jurkat cell adhesion assay was typically <10% for each experiment and no normalization was needed [1].
动物实验
For biliary excretion studies in mice and rats, a cannula (polyethylene tube, SP8 for mice and SP10 for rats) was inserted into the bile duct of the anesthetized animal. In the rat, after complete recovery from diethyl ether anesthesia, TR-14035 was administered intravenously at a dose of 3 mg/ml/kg, and the bile, urine, and blood were collected at designated time intervals. In the mouse, TR-14035 was administered intravenously at a dose of 3 mg/4 ml/kg, and the bile and blood were collected at designated time intervals under pentobarbital anesthesia. Blood was centrifuged to separate plasma, and all the samples were stored at j20 -C until analysis by LC-MSD [2].
别名MDK-1191
化学信息
分子量474.33
分子式C24H21Cl2NO5
CAS No.232271-19-1
SmilesCOc1cccc(OC)c1-c1ccc(C[C@H](NC(=O)c2c(Cl)cccc2Cl)C(O)=O)cc1
密度1.333 g/cm3
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
H2O: Insoluble
DMSO: 40 mg/Ml (84.3 mM)
溶液配制表
1mg5mg10mg50mg
1 mM2.1082 mL10.5412 mL21.0824 mL105.4118 mL
5 mM0.4216 mL2.1082 mL4.2165 mL21.0824 mL
10 mM0.2108 mL1.0541 mL2.1082 mL10.5412 mL
20 mM0.1054 mL0.5271 mL1.0541 mL5.2706 mL
50 mM0.0422 mL0.2108 mL0.4216 mL2.1082 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

评论列表

4个月前
5.0
Rating icon 很棒

评论内容

Related Tags: buy TR-14035 | purchase TR-14035 | TR-14035 cost | order TR-14035 | TR-14035 chemical structure | TR-14035 in vivo | TR-14035 in vitro | TR-14035 formula | TR-14035 molecular weight